TECregen AG

TECregen AG is a public limited company based in Basel, founded in 2023. The company’s purpose is to develop, manufacture and distribute pharmaceutical and other healthcare products as well as develop, hold and exploit intellectual property rights in this area.

News

News

CHF 10M – Closed seed financing round in January 2026

accelerating regenerative therapy development directly from Tech Park labs.

Building B
Industry Biotech
Employees 4
Founding year 2023